Rituxan has significant activity in patients with CLL
, 48 , 303-307, doi: Dequanter, D., Van De Velde, M., Bar, I., Nuyens, V., Rousseau, A., Nagy, N., Vanhamme, L., Vanhaeverbeek, M., Brohe, D., Delre, P., Boudjeltia, K., Lothaire, P., and Uzureau, P
May be used at 5-10 mM to elute glutathione S-transferase (GST) from glutathione agarose
Glutathione IV therapy works systemically (from the inside) rather than topically, so it is generally suitable for all skin types including sensitive skin
Overall, this work proposed a convenient, safe, and effective rectal drug delivery strategy, providing a new candidate for the prevention and treatment of radiation-induced proctitis, and also providing a reference for the design of multifunctional local delivery systems in radiation-associated tissue injury